Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothy Fallows

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Plos One|May 3, 2017
A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosisSelena Ferrian, Claudia Manca, Sugnet Lubbe, et al.
Journal of Clinical Microbiology|August 5, 2016
Evaluation of Semiautomated IS6110-Based Restriction Fragment Length Polymorphism Typing for Mycobacterium tuberculosis in a High-Burden SettingHalima M Said, Keshav Krishnamani, Shaheed V Omar, et al.
Open Biology|May 31, 2012
Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune responseSelvakumar Subbian, Liana Tsenova, Guibin Yang, et al.
The American Journal of Pathology|September 11, 2012
Spontaneous latency in a rabbit model of pulmonary tuberculosisSelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Frontiers in Immunology|November 10, 2018
Frequency of Circulating CD4<sup>+</sup>Ki67<sup>+</sup>HLA-DR<sup>-</sup> T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture ConversionSelena Ferrian, Melinda Ross, Francesca Conradie, et al.
Plos Pathogens|September 28, 2011
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungsSelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Emerging Microbes & Infections|June 4, 2015
'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibilityYing Zhang, Kwok Chiu Chang, Chi-Chiu Leung, et al.
The American Journal of Pathology|June 28, 2011
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathologySelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Plos One|March 3, 2011
Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected miceMi-Sun Koo, Claudia Manca, Guibin Yang, et al.
The Journal of Infectious Diseases|September 22, 2009
Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalenceKeren Middelkoop, Linda-Gail Bekker, Barun Mathema, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Plos One|May 3, 2017
A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosisSelena Ferrian, Claudia Manca, Sugnet Lubbe, et al.
Journal of Clinical Microbiology|August 5, 2016
Evaluation of Semiautomated IS6110-Based Restriction Fragment Length Polymorphism Typing for Mycobacterium tuberculosis in a High-Burden SettingHalima M Said, Keshav Krishnamani, Shaheed V Omar, et al.
Open Biology|May 31, 2012
Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune responseSelvakumar Subbian, Liana Tsenova, Guibin Yang, et al.
The American Journal of Pathology|September 11, 2012
Spontaneous latency in a rabbit model of pulmonary tuberculosisSelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Frontiers in Immunology|November 10, 2018
Frequency of Circulating CD4<sup>+</sup>Ki67<sup>+</sup>HLA-DR<sup>-</sup> T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture ConversionSelena Ferrian, Melinda Ross, Francesca Conradie, et al.
Plos Pathogens|September 28, 2011
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungsSelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Emerging Microbes & Infections|June 4, 2015
'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibilityYing Zhang, Kwok Chiu Chang, Chi-Chiu Leung, et al.
The American Journal of Pathology|June 28, 2011
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathologySelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Plos One|March 3, 2011
Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected miceMi-Sun Koo, Claudia Manca, Guibin Yang, et al.
The Journal of Infectious Diseases|September 22, 2009
Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalenceKeren Middelkoop, Linda-Gail Bekker, Barun Mathema, et al.
Pageof 3